Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

Archive ouverte

Dobi, Erion | Bazan, Fernando | Dufresne, Armelle | Demarchi, Martin | Villanueva, Cristian | Chaigneau, Loic | Montcuquet, Philipe | Ivanaj, Arben | Sautière, Jean Loup | Maisonnette-Escot, Yolande | Cals, Laurent | Algros, Marie Paule | Woronoff, Anne-Sophie | Pivot, Xavier

Edité par CCSD ; Springer Verlag -

International audience. BACKGROUND: This study searched for extra capsular tumour spread (ECS) as a prognostic factor for recurrence in terms of Disease Free Survival (DFS) and Overall Survival (OS). PATIENTS AND METHODS: For this study, from a retrospective database of the Doubs cancer registry, 823 eligible women with node positive breast cancer treated from February 1984 to November 2000 were identified. The following factors were evaluated: ECS, numbers of involved nodes, histological tumour grade, tumour size, status of estrogen and progesterone receptors, and age of patient. A Cox proportional hazards method was used to search for significant factors related to OS and DFS length. RESULTS: In the multivariate analysis, factors related to DFS length were found to be: tumour grade (aHR 0.76, 95 % CI 0.61-0.96, p = 0.02), ECS status (aHR 0.7, 95 % CI 0.49-0.96, p = 0.03), progesterone (PgR) status (aHR 0.63, 95 % CI 0.44-0.85 p = 0.008), number of nodes involved (aHR 0.75, 95 % CI 0.56-1, p = 0.05). The multivariate analysis for OS found as significant factors: tumour grade (aHR 0.76, 95 % CI 0.61-0.95; p = 0.02) and PgR status (aHR 0.8, 95 % CI 0.56-0.99, p = 0.02). CONCLUSIONS: This study might suggest taking into account ECS status in the adjuvant decision-making process.

Consulter en ligne

Suggestions

Du même auteur

First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis.

Archive ouverte | Nerich, Virginie | CCSD

International audience. AIM: To carry out a cost minimisation analysis including a comparison of the costs arising from first-line treatment by bevacizumab plus docetaxel (BD) versus bevacizumab plus paclitaxel (BP)...

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Archive ouverte | Curtit, Elsa | CCSD

International audience. Anthracycline extravasation is an uncommon but very serious complication. Very few data are available in the literature concerning the consequences and the management of extravasation of lipo...

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry

Archive ouverte | Selmani, Zohair | CCSD

International audience. Abstract Breast cancers expressing high levels of Ki67 are associated with poor outcomes. Oncotype DX test was designed for ER+/HER2− early-stage breast cancers to help adjuvant chemotherapy ...

Chargement des enrichissements...